Joline S.W. Lind

Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients

Anouk M Corstjens, Jack J. M. Ligtenberg, Iwan CC van der Horst et al. · Critical Care · 2006 · 163 citations · Full text

Medicine, Critical Care Nursing, Critical Care Pharmacology +16

Simple and selective method for the determination of various tyrosine kinase inhibitors used in the clinical setting by liquid chromatography tandem mass spectrometry

Richard J. Honeywell, K. Yarzadah, Elisa Giovannetti et al. · Journal of Chromatography B · 2010 · 95 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +15

A Multicenter Phase II Study of Erlotinib and Sorafenib in Chemotherapy-Naïve Patients with Advanced Non–Small Cell Lung Cancer

Joline S.W. Lind, Anne‐Marie C. Dingemans, Harry J.M. Groen et al. · Clinical Cancer Research · 2010 · 85 citations · Full text

Medicine, Oncology, Pharmacology +17

Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

Joline S.W. Lind, Martijn R. Meijerink, Anne‐Marie C. Dingemans et al. · European Radiology · 2010 · 85 citations · Full text

Medicine, Oncology, Radiology +17

Phase I Study of Concurrent Whole Brain Radiotherapy and Erlotinib for Multiple Brain Metastases From Non–Small-Cell Lung Cancer

Joline S.W. Lind, Frank J. Lagerwaard, Egbert F. Smit et al. · International Journal of Radiation Oncology*Biology*Physics · 2009 · 67 citations

Medicine, Oncology, Radiation Oncology +12